KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardlytics (CDLX) Cash from Investing Activities (2017 - 2026)

Cardlytics filings provide 10 years of Cash from Investing Activities readings, the most recent being -$2.3 million for Q1 2026.

  • Quarterly Cash from Investing Activities rose 40.97% to -$2.3 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$13.7 million through Mar 2026, up 23.46% year-over-year, with the annual reading at -$15.3 million for FY2025, 18.37% up from the prior year.
  • Cash from Investing Activities hit -$2.3 million in Q1 2026 for Cardlytics, down from -$2.3 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at -$1.4 million in Q4 2023 and bottomed at -$5.3 million in Q3 2024.
  • Average Cash from Investing Activities over 5 years is -$3.7 million, with a median of -$3.9 million recorded in 2025.
  • The largest annual shift saw Cash from Investing Activities soared 98.77% in 2022 before it plummeted 198.9% in 2024.
  • Cardlytics' Cash from Investing Activities stood at -$3.2 million in 2022, then skyrocketed by 56.64% to -$1.4 million in 2023, then plummeted by 198.9% to -$4.1 million in 2024, then surged by 44.27% to -$2.3 million in 2025, then fell by 1.19% to -$2.3 million in 2026.
  • Per Business Quant, the three most recent readings for CDLX's Cash from Investing Activities are -$2.3 million (Q1 2026), -$2.3 million (Q4 2025), and -$4.5 million (Q3 2025).